Skip to content

Lars Michels

Department of Neuroradiology, University Hospital Zurich, Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.

5 papers in the library · 217 citations · publishing 2017-2024

Papers

Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow

NeuroImage July 12, 2017 Candace R. Lewis, Katrin H. Preller, Rainer Kraehenmann et al. 105 citations

Psilocybin, a hallucinogen, significantly enhances cerebral blood flow in key brain regions. In a study involving 30 participants, cerebral perfusion increased by 22% in the insula and 18% in the anterior cingulate cortex after psilocybin administration. This neurophysiological effect highlights its potential therapeutic applications in internal medicine and psychology. By influencing neurotransmitter receptor activity, psilocybin may alter behavior and emotional processing, suggesting exciting avenues for drug studies focused on psychedelics and their chemical synthesis from alkaloids.

Triple Network Model Dynamically Revisited: Lower Salience Network State Switching in Pre-psychosis

Frontiers in Physiology February 11, 2020 Thomas A. W. Bolton, Diana Wotruba, Roman Buechler et al. 83 citations

Altered coordination between the default mode, central executive, and salience networks is linked to schizophrenia, but its role in earlier at-risk stages is unclear. Using dynamic functional connectivity and co-activation pattern analysis of resting-state fMRI, this study examined right anterior insula interactions in 19 individuals with subthreshold delusions and hallucinations (UHR), 28 with basic symptoms of self-experienced subclinical disturbances (BS), and 29 healthy controls. The right anterior insula governs transitions from the central executive to default mode network, which become dysfunctional before psychosis onset, especially when attenuated psychotic symptoms emerge.

Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.

Scientific reports March 26, 2024 Berit Singer, Daniel Meling, Matthias Hirsch-Hoffmann et al. 15 citations

Brain activity patterns during meditation shift after a psilocybin-assisted retreat, especially when open-monitoring meditation is practiced. Using functional MRI and a topological data analysis method (Mapper), researchers compared experienced meditators who received psilocybin or placebo over five days. The psilocybin group showed a link between positive derealization—an altered perception that can foster insight—and a greater geometric distance between open-monitoring meditation and resting-state brain activity, as measured by optimal transport distance. This suggests that combining psilocybin with open-monitoring practice enhances meta-awareness and insight. The findings point to possible brain markers for synergistic effects between mindfulness and psychedelics.

Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.

Scientific reports October 14, 2023 Nathalie M Rieser, Ladina P Gubser, Flora Moujaes et al. 14 citations

Psilocybin alters cerebral blood flow in the brain, and the magnitude of these changes depends on individual baseline psychological and neurobiological characteristics. In a placebo-controlled study of 70 healthy participants given one of three oral doses of psilocybin, reductions in relative cerebral blood flow correlated with both baseline traits and the intensity of the subjective psychedelic experience. The findings demonstrate that inter-individual heterogeneity in the neural response to psilocybin is linked to pre-existing differences, helping to identify biomarkers for a personalized medicine approach in psychedelic-assisted therapy.